Nova Southeastern University Office of Academic Affairs Search NSU Site Map Nova Southeastern University
President's Faculty R & D Grant 
Committees, Councils
  and Boards
Faculty Policy Manual
NSU Scholarly Journals
Professional Journals
Prof. Memberships
Academic Policies & Procedures
Provost's Research and Scholarship Award
President's Faculty
 R & D Grant
PFRDG Application Review Process by NSU Librarians
Office of Academic Quality, Assessment, and Accreditation
Contact Us

Print this page  


With a focus on learning, we employ a range of strategies to support innovation, collaboration across centers, and university-wide discussion and decision-making


Fifth Annual Grant Winners 2004-2005

Michelle Clark, Ph.D., HPD – College of Pharmacy
Ana Maria Castejon, Ph.D., HPD – College of Pharmacy

Dean William Hardigan, HPD – College of Pharmacy

Title: Dysregulation of AT 1 receptor Signaling in the (mRen2)27 Transgenic Rat


Hypertension is a major health problem in the United States where more than 50 million people have the condition. Chronic hypertension can lead to vital organ damage and contributes to more than 500,000 deaths in the United States annually. Angiotensin II (Ang II) is a biologically active octapeptide that triggers a myriad of physiological responses that may lead to hypertension. This project will use a hypertensive rat model known as the mRen2(27) transgenic rats to look at the effects of Ang II on hypertension. These hypertensive rats have overexpression of a gene for one of the proteins implicated in blood pressure regulation –renin. There is also a chronic increase in Ang II in their brain and blood vessels that ultimately results in an elevation of blood pressure. Astrocytes will be isolated from the brains of normotensive and hypertensive rats and studies outlined in this proposal will: (a) identify intracellular mechanisms responsible for dysregulation of the Ang II receptor in the transgenic rat by studying the regulation of the SAPK/JNK pathway and; (b) determine the molecular consequences of this Ang II receptor dysregulation in the transgenic rat by studying the regulation of c-jun, ATF-2 and elk-1 expression in these animals. The studies proposed are designed to determine whether effects of chronic elevation in Ang II may be overcome. Further, since in most cases the underlying cause of hypertension is not known, understanding how different types of cells are affected by long-term exposure to angiotensin molecules and how they, in turn, regulate blood pressure will allow us to design better drugs for the prevention and treatment of hypertension.